Among them, 4 were found up-regulated in CD56neg CD16+ NK cells of AML patients, namely ZNF683, LAG3, FGL2 and CST7, involved in NK cell split anergy (29). The gene discussed is FGL2; the disease is acute myeloid leukemia.